IL97819A0 - Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases - Google Patents

Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases

Info

Publication number
IL97819A0
IL97819A0 IL97819A IL9781991A IL97819A0 IL 97819 A0 IL97819 A0 IL 97819A0 IL 97819 A IL97819 A IL 97819A IL 9781991 A IL9781991 A IL 9781991A IL 97819 A0 IL97819 A0 IL 97819A0
Authority
IL
Israel
Prior art keywords
folates
treatment
neoplastic diseases
acid conjugates
difluoroglutamic acid
Prior art date
Application number
IL97819A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL97819A0 publication Critical patent/IL97819A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
IL97819A 1990-04-12 1991-04-10 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases IL97819A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/508,874 US5066828A (en) 1990-04-12 1990-04-12 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases

Publications (1)

Publication Number Publication Date
IL97819A0 true IL97819A0 (en) 1992-06-21

Family

ID=24024432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97819A IL97819A0 (en) 1990-04-12 1991-04-10 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases

Country Status (18)

Country Link
US (1) US5066828A (de)
EP (1) EP0451835B1 (de)
JP (1) JP2970698B2 (de)
KR (1) KR910018344A (de)
CN (1) CN1055740A (de)
AT (1) ATE127778T1 (de)
AU (1) AU635628B2 (de)
CA (1) CA2040059A1 (de)
DE (1) DE69112885T2 (de)
ES (1) ES2079507T3 (de)
FI (1) FI911778L (de)
HU (1) HU911195D0 (de)
IE (1) IE911230A1 (de)
IL (1) IL97819A0 (de)
NO (1) NO911418L (de)
NZ (1) NZ237735A (de)
PT (1) PT97338A (de)
ZA (1) ZA912590B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
AU4220193A (en) * 1992-04-29 1993-11-29 Sri International Deazaaminopterins for treatment of inflammation
US6323205B1 (en) * 1996-07-17 2001-11-27 Sloan-Kettering Institute For Cancer Research Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors
DE19904812A1 (de) 1999-02-05 2000-08-10 Basf Ag Verfahren zur Herstellung von Folsäure
CN101646639A (zh) 2007-04-11 2010-02-10 默克阿泼洛发股份公司 18f-标记的叶酸
WO2008125615A1 (en) * 2007-04-11 2008-10-23 Merck Eprova Ag 18 f-labelled folates
US9901578B2 (en) 2007-08-17 2018-02-27 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20090048262A1 (en) * 2007-08-17 2009-02-19 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20100248249A1 (en) * 2007-08-17 2010-09-30 Allos Therapeutics, Inc. Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
CA2736861C (en) 2008-10-10 2017-11-14 Roger Schibli 18f-labelled folates as pet radiotracers
WO2011096947A1 (en) * 2010-02-02 2011-08-11 Allos Therapeutics, Inc. Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630380A5 (de) * 1977-08-12 1982-06-15 Lonza Ag Verfahren zur herstellung von l-methotrexat.
US4136101A (en) * 1978-02-03 1979-01-23 American Cyanamid Company Process for preparing dialkyl (p-aminobenzoyl) glutamates
US4247453A (en) * 1978-09-13 1981-01-27 Abbott Laboratories Folic acid derivatives for use in radioimmunoassay
IT1215169B (it) * 1985-12-17 1990-01-31 Rotta Research Lab Derivati alchil ossigenati degli acidi glutammico ed aspartico ad attivita antagonista su polipeptidi bioattivi e procedimento per la loro preparazione
NZ219971A (en) * 1986-06-06 1989-08-29 Univ Princeton Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions
EP0341837A3 (de) * 1988-04-15 1990-08-16 The Wellcome Foundation Limited Glutamsäurederivate

Also Published As

Publication number Publication date
JPH04235144A (ja) 1992-08-24
JP2970698B2 (ja) 1999-11-02
PT97338A (pt) 1992-01-31
IE911230A1 (en) 1991-10-23
NZ237735A (en) 1993-08-26
FI911778A7 (fi) 1991-10-13
ATE127778T1 (de) 1995-09-15
HU911195D0 (en) 1991-10-28
NO911418D0 (no) 1991-04-11
CN1055740A (zh) 1991-10-30
US5066828A (en) 1991-11-19
DE69112885D1 (de) 1995-10-19
FI911778A0 (fi) 1991-04-12
DE69112885T2 (de) 1996-02-15
CA2040059A1 (en) 1991-10-13
ZA912590B (en) 1992-01-29
EP0451835A1 (de) 1991-10-16
ES2079507T3 (es) 1996-01-16
KR910018344A (ko) 1991-11-30
EP0451835B1 (de) 1995-09-13
AU635628B2 (en) 1993-03-25
AU7416591A (en) 1991-10-17
FI911778L (fi) 1991-10-13
NO911418L (no) 1991-10-14

Similar Documents

Publication Publication Date Title
EP0451836A3 (en) Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
MXPA02008233A (es) Compuestos de pteridina para tratamiento de psoriasis.
DE3569332D1 (en) Porphyrins and cancer treatment
ZA912590B (en) Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
RU1833372C (ru) Cпocoб пoлучehия пpoизboдhыx 2,4,5-зameщehhыx бehзoлa
DE69821498D1 (de) Verwendung von amifostin
ATE372774T1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
DE69402576D1 (de) Cytotoxische und antivirale Verbindung
CY2207B1 (en) Pharmaceutical for the treatment f skin disorders
PL341707A1 (en) Compounds exibiting growth hormone releasing properties
IT1223395B (it) Composti ad attivita' cardiovascolare
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
TR199701605A2 (xx) S�lfonamid-substit�e edilmi� bile�ikler
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.